Vish Seshadri, Abeona Therapeutics CEO
June 9, 2023 11:09 AM EDT
R&D
Cell/Gene Tx
Manufacturing

FDA wants more da­ta from Abeona Ther­a­peu­tics as it push­es for BLA

Tyler Patchen

News Reporter

Abeona Ther­a­peu­tics pushed back plans to sub­mit its gene ther­a­py for a rare skin con­di­tion af­ter the FDA asked the com­pa­ny for more da­ta about …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times